State the application's broad^B-term objectives and specific aims, making referend^Bthe health relatedness of the project. Describe concisely the research design and methods fwPfhieving these goals. Avoid summaries of past accCT^FIshments and the use of the first person. This description is meant to serve as a succinct and accurate description of the proposed work when separatedfrom the application. If the application is funded, this description, as is, will become public information. Therefore, do not include proprietary/confidential information. DO NOT EXCEED THE SPACE PROVIDED. The GI training program of the Massachusetts General Hospital (MGH) is dedicated to the preparation of investigators committed to a career in GI biomedical research. This program continues to build on its outstanding past experience in establishing productive and committed investigators. Fundamental features of the post-doctoral training format, the major component of this program, include -direct research participation in conjunction with a comprehensive program of didactic instruction and enrichment activities to provide a deep foundation in biomedical science and modern research techniques. In addition, a two-year pre-doctoral laboratory research program is proposed to attract minority students to careers in GI research. (A) Research Areas and Disciplines. Although the strength of the research base of this program encompasses a spectrum of research interests, an intensive experience in the related basic disciplines is a common element of each trainee's experience. The majority of trainees will undertake training in laboratory research in which emphasis is placed on the application of tools of molecular biology to GI research. Training is offered in several disciplines: Molecular Biology, Biochemistry, Membrane Biology, Developmental Biology, Genetics, and Immunology. These disciplines are applied to nine research themes central to the current study of digestive diseases. For the few trainees undertaking training in clinical investigation, a rigorous preparation in relevant quantitative sciences, includingBiostatistics and Epidemiology, is provided. (B) Level of Training. Background and Numbers of Trainees. This renewal proposes both post-doctoral and pre-doctoral training. Post-doctoral training is offered to individuals holding M.D.,M.D.-Ph.D. or relevant Ph.D. degrees. Six post-doctoral positions are requested: three post-doctoral fellows will begin training each year, and remain in research training for a minimum of two years supported by this award. In addition, two positions are requested to continue the recently initiated pre-doctoral training fellowship for minority students completing an undergraduate degree or enrolled in medical school. (C) Training Facilities. Research training will take place in the existing laboratories of the research mentors; a group of established investigators with extensive existing interactions. Laboratories are present in the main campus of the MGH,a large general hospital with more than 250,000 sq. ft. of space dedicated to research, as well as its new campus designated MGH-East, comprised of more than 400,000 sq. ft. of additional research space. In addition, training opportunities will be available in laboratories of the Whitehead Institute (M.l.T. and Harvard University). Didactic educational programs will include those offered through the Harvard Medical School, the Harvard School of Public Health, Harvard University and M.l.T. PERFORMANCE SITE(S)(organization, city, state) Massachusetts General Hospital, Boston, MA (MGH) KEY PERSONNEL. See instructions on Page 11. Use continuation pages as needed to provide the required information in the format shown below. Name Organization Role on Project Podolsky, MD, Daniel K. Massachusetts General Hospital (MGH)/ Director Harvard Medical School (HMS) Alt, Ph.D., Frederick W. Children's Hospital Preceptor Arnaout, M.D., Amin M MGH/HMS Preceptor Ausiello, M.D., Dennis A. MGH/HMS Preceptor Avruch, M.D., Joseph MGH/HMS Preceptor Bhan, M.D,Atul K. MGH/HMS Preceptor Brown, Ph.D., Dennis MGH/HMS Preceptor Calderwood, M.D., Stephen B. MGH/HMS Preceptor Chung, M.D., Daniel C. MGH/HMS Preceptor Chung, M.D., Raymond T. MGH/HMS Preceptor Dienstag, M.D., Jules L. MGH/HMS Preceptor - Fishman, M.D., Mark C. MGH/HMS Preceptor Goldberg, M.D., Marcia MGH/HMS Preceptor Habener, M.D., Joel MGH/HMS Preceptor PHS 398 (Rev. 4/98) Page 2 BB Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 3b. ? BB Principal Investigator/Program Director (Last, first, middle): Podolsky. Daniel K. Haber, M.D., Ph.D., Daniel A. H/HMS Preceptor Harlow, Jr.,Ph.D., Edward E. H/HMS Preceptor Kaplan, M.D., Ph.D., Lee M. MGH/HMS Preceptor Kirschner, Ph.D., Marc W. HMS Preceptor Koh, M.D, Theodore J. MGH/HMS Preceptor Luster, M.D, AndrewD. MGH/HMS Preceptor Mashimo, M.D,Ph.D., Hiroshi MGH/HMS Preceptor Melton, Ph.D., Douglas A. Harvard University Preceptor Mulley, M.D, Albert G. MGH/HMS Preceptor Nagler-Anderson, Cathryn MGH/HMS Preceptor Nishioka, M.D, Norman S. MGH/HMS Preceptor Filial, M.D, Ph.D., Shiv S. MGH/HMS Preceptor Reinecker, M.D,Hans-Christian MGH/HMS Preceptor Sachs, M.D, David H. MGH/HMS Preceptor Sands, M.D, Bruce E. MGH/HMS Preceptor Schmidt, M.D, Ph.D., Emmett V. MGH/HMS Preceptor Seed, Ph.D., Brian MGH/HMS Preceptor Singer, M.D, Daniel E. MGH/HMS Preceptor Snapper, M.D, Ph.D., Scott B. MGH/HMS Preceptor Takahashi, M.D,Ph.D,Hiroshi MGH/HMS Preceptor Walker, M.D, W. Allan MGH/HMS Preceptor Wang, M.D, Timothy C. MGH/HMS Preceptor Xavier, M.D, Ramnik J. MGH/HMS Preceptor PHS 398 (Rev. 4/98) Page 3 BB Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 3b. X NN Principal Investigator/Program Director (Last, first, middle): Podolsky. Daniel K. Type the name of the program director at thd^Hof each printed page and each continuation page.^Hr type specifications, see instructions on page 6.) INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARD (Substitute Page)

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
3T32DK007191-32S1
Application #
7234240
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
1976-07-01
Project End
2011-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
32
Fiscal Year
2006
Total Cost
$29,010
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Simon, Tracey G; King, Lindsay Y; Chong, Dawn Q et al. (2018) Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology 67:1797-1806
Takahashi, Melissa K; Tan, Xiao; Dy, Aaron J et al. (2018) A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers. Nat Commun 9:3347
Pereira, Ethel R; Kedrin, Dmitriy; Seano, Giorgio et al. (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403-1407
Kubiliun, Maddie; Patel, Suraj J; Hur, Chin et al. (2018) Early liver transplantation for alcoholic hepatitis: Ready for primetime? J Hepatol 68:380-382
Chhatwal, J; Chen, Q; Ayer, T et al. (2018) Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA. Aliment Pharmacol Ther 47:1023-1031
Graham, Daniel B; Jasso, Guadalupe J; Mok, Amanda et al. (2018) Nitric Oxide Engages an Anti-inflammatory Feedback Loop Mediated by Peroxiredoxin 5 in Phagocytes. Cell Rep 24:838-850
Bhan, Irun; Mosesso, Kelly; Goyal, Lipika et al. (2018) Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease. Gastroenterology 155:2016-2018.e11
Chhatwal, Jagpreet; Samur, Sumeyye; Bethea, Emily D et al. (2018) Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study. Hepatology 67:2085-2095
Bethea, Emily D; Chen, Qiushi; Hur, Chin et al. (2018) Should we treat acute hepatitis C? A decision and cost-effectiveness analysis. Hepatology 67:837-846
Chen, Jennifer Y; Newcomb, Benjamin; Zhou, Chan et al. (2017) Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells. Sci Rep 7:44867

Showing the most recent 10 out of 149 publications